The fund seeks capital appreciation by investing in companies across any size in the United States.
The investment process starts with a list of companies in the benchmark index and the research team utilizes quantitative techniques and fundamental analysis to identify investment opportunities.
Next, the research team focuses on companies that exhibit superior capital appreciation potential.
Then the manager constructs a diversified portfolio from a list of companies in the benchmark index favored by the research team and allocates capital based on its conviction level.
The portfolio is invested across a range of industry sectors, however the financial services, technology and/or pharmaceutical/health care sectors are likely to be overweight compared to others.
Also, the manager is not constrained by sector to identify potential investment opportunities.
The fund has the flexibility to invest up to 45% of its net assets in securities of foreign issuers, including multinational and emerging market securities.
The fund is non-diversified, which means that it may take larger positions in a small number of companies than a diversified fund.
Additionally, the fund has the flexibility to take temporary defensive positions in cash or cash equivalents in response to adverse market, economic, political, or other conditions.
